Explore

Communities in English

Advertise on Engormix

Merck introduces PRRS vaccine in the US

Published: October 17, 2014
Source : Joseph Harvey (MSD)
Merck Animal Health has introduced a vaccine for reducing clinical signs linked to porcine reproductive and respiratory syndrome virus (PRRS).

Prime PAC PRRS+ is designed to reduce clinical signs of reproductive disease in female breeding-age swine, as well as respiratory disease in pigs three to four weeks of age and older due to PRRS.
PRRS has caused losses for the US breeding and growing-pig herd market of around $664 million annually.

According to Merck, clinical trial results showed that vaccination with Prime significantly reduced viremia and the clinical signs of PRRS. The vaccine also provided four months duration of immunity, helping herds remain as productive as possible. Prime is available in 20ml and 100ml packages, as well as a 600-sow/1200-piglet-dose bulk pack.

Merck's business outside of North America, MSD Animal Health, claims its PRRS vaccine is effective against different strains of the porcine virus in Asia.

Boehringer Ingelheim markets its Ingelvac PRRS vaccine, which in 2012 was the product with the highest sales growth rate in 2012 for the company.
Source
Joseph Harvey (MSD)
Related topics:
Recommend
Comment
Share
Profile picture
Would you like to discuss another topic? Create a new post to engage with experts in the community.
Featured users in Pig Industry
Chris Parks
Chris Parks
Cargill
United States
Karo Mikaelian
Karo Mikaelian
Trouw Nutrition
United States
Tom Frost
Tom Frost
DSM-Firmenich
Director of Innovation & Application
United States
Join Engormix and be part of the largest agribusiness social network in the world.